CRAF R391W is a melanoma driver oncogene

por Atefi, Mohammad, Titz, Bjoern, Tsoi, Jennifer, Avramis, Earl, Le, Allison, Ng, Charles, Lomova, Anastasia, Lassen, Amanda, Friedman, Michael, Chmielowski, Bartosz, Ribas, Antoni, Graeber, Thomas G.
Publicado 2016

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma

por Atefi, Mohammad, Titz, Bjoern, Avramis, Earl, Ng, Charles, Wong, Deborah JL, Lassen, Amanda, Cerniglia, Michael, Escuin-Ordinas, Helena, Foulad, David, Comin-Anduix, Begonya, Graeber, Thomas G, Ribas, Antoni
Publicado 2015

PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody

por Escuin-Ordinas, Helena, Elliott, Mark W, Atefi, Mohammad, Lee, Michelle, Ng, Charles, Wei, Liu, Comin-Anduix, Begoña, Montecino-Rodriguez, Encarnacion, Avramis, Earl, Radu, Caius, Sharp, Leslie L, Ribas, Antoni
Publicado 2013

Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products

por Nowicki, Theodore S., Escuin-Ordinas, Helena, Avramis, Earl, Chmielowski, Bartosz, Chodon, Thinle, Berent-Maoz, Beata, Wang, Xiaoyan, Kaplan-Lefko, Paula, Yang, Lili, Baltimore, David, Economou, James S., Ribas, Antoni, Comin-Anduix, Begoña
Publicado 2018

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

por Wong, Deborah JL, Robert, Lidia, Atefi, Mohammad S, Lassen, Amanda, Avarappatt, Geetha, Cerniglia, Michael, Avramis, Earl, Tsoi, Jennifer, Foulad, David, Graeber, Thomas G, Comin-Anduix, Begonya, Samatar, Ahmed, Lo, Roger S, Ribas, Antoni
Publicado 2014

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

por Wong, Deborah JL, Robert, Lidia, Atefi, Mohammad S, Lassen, Amanda, Avarappatt, Geetha, Cerniglia, Michael, Avramis, Earl, Tsoi, Jennifer, Foulad, David, Graeber, Thomas G, Comin-Anduix, Begonya, Samatar, Ahmed, Lo, Roger S, Ribas, Antoni
Publicado 2015

Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab

por Ibarrondo, F. Javier, Yang, Otto O., Chodon, Thinle, Avramis, Earl, Lee, Yohan, Sazegar, Hooman, Jalil, Jason, Chmielowski, Bartosz, Koya, Richard C., Schmid, Ingrid, Gomez-Navarro, Jesus, Jamieson, Beth D., Ribas, Antoni, Comin-Anduix, Begoña
Publicado 2013